XML 24 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Retained Earnings (Accumulated deficit)
Series A preferred stock
Series B preferred stock
Beginning balance at Dec. 31, 2019 $ (36,088) $ 1   $ (224) $ (35,865)    
Temporary equity, beginning balance (in shares) at Dec. 31, 2019           6,167,726 20,942,781
Temporary equity, beginning balance at Dec. 31, 2019           $ 5,353 $ 46,404
Beginning balance (in shares) at Dec. 31, 2019   256,548          
Issuance of Preferred Stock             $ 125,026
Issuance of Preferred Stock (in shares)             44,453,477
Settlement of preferred stock tranche right 4,135   $ 4,135        
Accretion of Series B and B-2 Preferred Stock to redemption value 5,120   5,120       $ (5,120)
Conversion of redeemable convertible preferred stock to common stock upon closing of initial public offering 181,903 $ 22 181,881     $ (5,353) $ (176,550)
Conversion of redeemable convertible preferred stock to common stock upon closing of initial public offering, Shares   22,460,076       (6,167,726) (65,396,258)
Issuance of common stock from initial public offering 210,612 $ 12 210,600        
Issuance of common stock from initial public offering, shares   12,091,675          
Stock-based compensation 4,292   4,292        
Common stock issued upon exercises of options 655   655        
Common stock issued upon exercises of options (in shares)   236,459          
Currency translation adjustment 841     841      
Net income (loss) (38,033)       (38,033)    
Ending balance at Dec. 31, 2020 323,197 $ 35 396,443 617 73,898    
Ending balance (in shares) at Dec. 31, 2020   35,044,758          
Settlement of preferred stock tranche right            
Stock-based compensation 13,794   13,794        
Common stock issued upon exercises of options $ 2,943   2,943        
Common stock issued upon exercises of options (in shares) 421,947 421,243          
Currency translation adjustment $ (1,635)     (1,635)      
Net income (loss) 214,521       214,521    
Ending balance at Dec. 31, 2021 $ 552,820 $ 35 $ 413,180 $ (1,018) $ 140,623    
Ending balance (in shares) at Dec. 31, 2021   35,466,001